This page follows insider dealings at PNR as filed with ASX, a company from the Chemicals sector. The last twelve months, up to 18 October 2026, brought 7 filings signed by 4 insiders.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
With 7 filings in twelve months, the company is more active than the median of 3 filings across the 2,530 companies we follow on the same exchange.
Insider buying of PNR has been absent for the past year.
For comparison within the same sector, see the insider buying recorded at Culp Inc. Source: insider filings from ASX. Past trades are no guide to future returns.
Analysts rate PNR Strong Buy (bullish), based on 6 analysts. Average price target: A$3.71.
Transparent value + quality ranking, distinct from the insider signal.
FY ended June 2025 · cache
7 of 7 declarations
PNR is a company operating in the chemical and materials sector. It is listed on the XASX market.
Purchases our model currently ranks for the recommendations list.
All recommendations